true partners in...
orchestrating transformational deals so our client can develop transformational drugs.
HARMONY BIOSCIENCES
Financings / M&A / Strategic Advisor / Investor
Acquisition of Pitolisant from Bioprojet
$270 million Equity Financing from investors/affiliates of Paragon Biosciences, Valor Equity Partners, Fidelity Management & Research, HBM Healthcare Investments, Vivo Capital, venBio Partners, Novo Holdings and Nan Fung Life Sciences.
Harmony Biosciences